Clinical trials in women's health research: Part II phase IV clinical research and beyond

Journal of Women's Health

Volumn 5, Issue 4, 1996, Pages 303-309

  Moore, Donnica L ^a   Bernard, Stan ^b  

^a Sandoz Pharma Ltd   (Switzerland)

^b AT Kearney Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DRUG DEVELOPMENT; DRUG INDUSTRY; FEMALE; HUMAN; PHARMACOECONOMICS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0029767952     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1996.5.303     Document Type: Review

References (11)

1. Moore DL, Bernard SB. Pharmaceutical industry update: Clinical trials in women's health research. Part I: The drug discovery and development process. J Women's Health 1996;5:103.
2. Mossinghoff G. New drug approvals in 1995. Washington, DC: Pharmaceutical Researchers and Manufacturers of America, 1996.
3. Spilker B. Multinational drug companies: Issues in drug discovery and development. New York: Raven Press, 1989.
4. Ellwood PM. Outcomes management: A technology of patient experience. N Engl J Med 1988;318:1549.
5. Townsend RJ. Post-marketing drug research and development. Drug Intell Clin Pharm 1987;21:134.
6. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. Cincinnati, OH, Harvey Whitney Books Company: 1991:4.
7. Cascade EF, Steinfels GF. Nonclinical trials. R & D Directions 1996;2:14.
8. Horn SD, Hopkins DSP, eds. Clinical practice improvement: A new technology for developing cost-effective quality health care. New York: Faulkner and Gray, Inc., 1994:2.
9. Classen DC, et al. Prophylactic antibiotics used to prevent surgical wound infections. In: Horn SD, Hopkins DSP, eds. Clinical practice improvement: A new technology for developing cost-effective quality health care. New York: Faulkner and Gray, Inc., 1994:217.
10. Smith MC. Pharmaceutical marketing: Strategy and cases. New York: Pharmaceutical Products Press, 1991.
11. Hawks JW, Levy RA. Boosting script yield: Healthy Rx for the nineties. Pharm Exec April 1993:22.